UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWNK
1251
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $4.26M | ﹤0.01% |
171,394
+16,666
| +11% | +$392K |
|
1252
Astec Industries
ASTE
$1B
| $4.26M | ﹤0.01% |
+103,154
| New | +$4.36M |
|
|
CADE
1253
DELISTED
Cadence Bank
CADE
| $4.25M | ﹤0.01% |
204,769
+8,480
| +4% | +$211K |
|
1254
Ultragenyx Pharmaceutical
RARE
$2.59B
| $4.25M | ﹤0.01% |
105,967
-15,952
| -13% | -$685K |
|
1255
Sanmina
SANM
$11B
| $4.25M | ﹤0.01% |
69,667
-2,338
| -3% | -$140K |
|
1256
Onto Innovation
ONTO
$14.8B
| $4.24M | ﹤0.01% |
48,265
+264
| +0.5% | +$21.4K |
|
1257
Federal Signal
FSS
$7.74B
| $4.21M | ﹤0.01% |
77,719
+6,019
| +8% | +$315K |
|
1258
Biohaven
BHVN
$2.21B
| $4.21M | ﹤0.01% |
+308,076
| New | +$4.9M |
|
1259
iRhythm Holdings
IRTC
$4.08B
| $4.18M | ﹤0.01% |
33,670
-965
| -3% | -$105K |
|
1260
Franklin Electric
FELE
$4.77B
| $4.16M | ﹤0.01% |
44,219
+2,039
| +5% | +$184K |
|
1261
Avient
AVNT
$4.18B
| $4.16M | ﹤0.01% |
101,031
+2,848
| +3% | +$114K |
|
1262
Goodyear
GT
$1.75B
| $4.15M | ﹤0.01% |
376,961
+32,631
| +9% | +$362K |
|
|
DNB
1263
DELISTED
Dun & Bradstreet
DNB
| $4.15M | ﹤0.01% |
353,656
+12,677
| +4% | +$161K |
|
|
HCP
1264
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $4.14M | ﹤0.01% |
141,312
+76,026
| +116% | +$2.27M |
|
1265
EnerSys
ENS
$6.83B
| $4.14M | ﹤0.01% |
47,595
+4,833
| +11% | +$407K |
|
|
WIRE
1266
DELISTED
Encore Wire Corp
WIRE
| $4.12M | ﹤0.01% |
22,252
+927
| +4% | +$158K |
|
|
EQC
1267
DELISTED
Equity Commonwealth
EQC
| $4.12M | ﹤0.01% |
198,735
-303,522
| -60% | -$7.04M |
|
1268
Hilton Grand Vacations
HGV
$3.33B
| $4.1M | ﹤0.01% |
92,379
-3,472
| -4% | -$157K |
|
1269
H.B. Fuller
FUL
$3.27B
| $4.08M | ﹤0.01% |
59,578
+3,016
| +5% | +$211K |
|
|
PCH
1270
DELISTED
PotlatchDeltic
PCH
| $4.07M | ﹤0.01% |
82,256
-7,873
| -9% | -$370K |
|
1271
Invesco Senior Loan ETF
BKLN
$6.74B
| $4.07M | ﹤0.01% |
+195,664
| New | +$4.1M |
|
1272
Ziff Davis
ZD
$1.99B
| $4.07M | ﹤0.01% |
52,101
+3,223
| +7% | +$264K |
|
1273
Cytokinetics
CYTK
$10.4B
| $4.07M | ﹤0.01% |
115,546
+18,254
| +19% | +$745K |
|
|
GAP
1274
The Gap Inc
GAP
$7.65B
| $4.06M | ﹤0.01% |
404,743
+46,890
| +13% | +$571K |
|
1275
First Hawaiian
FHB
$3.3B
| $4.04M | ﹤0.01% |
195,914
-12,836
| -6% | -$323K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.